Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2614)	3/24/2010 3:30:00 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

NVAX was up 16.23% at its intraday H and is still up 11.11% The stock opened with an UG. Volume of > 6M is about 4x its ADV bigcharts.marketwatch.com The stock has been forming a base at the $2.10 level and is not off from the DT coming from its Sep1 H at $7.79 bigcharts.marketwatch.com Ut announced today positive results from the entire 1,000 subject Stage A of its two-stage pivotal study evaluating the safety and immunogenicity of its 2009 A/H1N1 virus-like particle pandemic influenza vaccine.<g> The data showed that safety and immunogenicity of the vaccine were consistent with preliminary results, when the vaccine was found to be well tolerated and immunogenic at all three dose levels tested. Bernard